Results
|
4361.
|
|
|
4362.
|
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. [electronic resource] by
- Park, Margaret A
- Zhang, Guo
- Martin, Aditi Pandya
- Hamed, Hossein
- Mitchell, Clint
- Hylemon, Philip B
- Graf, Martin
- Rahmani, Mohamed
- Ryan, Kevin
- Liu, Xiang
- Spiegel, Sarah
- Norris, James
- Fisher, Paul B
- Grant, Steven
- Dent, Paul
Producer: 20090501
In:
Cancer biology & therapy vol. 7
Availability: No items available.
|
|
4363.
|
|
|
4364.
|
|
|
4365.
|
|
|
4366.
|
|
|
4367.
|
|
|
4368.
|
|
|
4369.
|
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial. [electronic resource] by
- Procopio, G
- Verzoni, E
- Bracarda, S
- Ricci, S
- Sacco, C
- Ridolfi, L
- Porta, C
- Miceli, R
- Zilembo, N
- Bajetta, E
Producer: 20110621
In:
British journal of cancer vol. 104
Availability: No items available.
|
|
4370.
|
|
|
4371.
|
|
|
4372.
|
|
|
4373.
|
|
|
4374.
|
|
|
4375.
|
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors. [electronic resource] by
- Richly, H
- Henning, B F
- Kupsch, P
- Passarge, K
- Grubert, M
- Hilger, R A
- Christensen, O
- Brendel, E
- Schwartz, B
- Ludwig, M
- Flashar, C
- Voigtmann, R
- Scheulen, M E
- Seeber, S
- Strumberg, D
Producer: 20061107
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|
|
4376.
|
|
|
4377.
|
|
|
4378.
|
|
|
4379.
|
Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors. [electronic resource] by
- Minami, Hironobu
- Kawada, Kenji
- Ebi, Hiromichi
- Kitagawa, Koichi
- Kim, Yon-il
- Araki, Kazuhiro
- Mukai, Hirofumi
- Tahara, Makoto
- Nakajima, Hikaru
- Nakajima, Keiko
Producer: 20080617
In:
Cancer science vol. 99
Availability: No items available.
|
|
4380.
|
|